Hunterdon Healthcare is offering monoclonal antibody treatment to COVID-19 positive outpatients. The monoclonal antibody treatment can be used to help COVID-19 patients with mild to moderate symptoms and who are at high risk of progressing to severe disease.
“Antibodies are proteins that our bodies make to fight viruses like the one that causes COVID-19. Antibodies that are made in a laboratory act like natural antibodies to fight the virus, stopping it from attaching to your cells and growing. It must be used early in the course of the infection before the virus has reached maximum growth. Monoclonal antibodies are directed against a specific virus, in this case the coronavirus that causes COVID-19,” explained Dr. Geralyn Prosswimmer, chief medical officer, Hunterdon Healthcare Partners. Prosswimmer added, “Monoclonal antibody treatment may reduce the chance of hospitalization for those at highest risk for severe disease. While not FDA approved, this product has emergency use authorization due to the pandemic.” Limited doses are supplied to hospitals by the state.
Monoclonal antibody treatment is given intravenously and is administered at Hunterdon Medical Center in a specially created infusion center. This treatment can be used for adults with mild to moderate COVID-19 symptoms who:
Patients who meet these criteria can discuss monoclonal antibody treatment with their Hunterdon Healthcare primary care physician. For more information call the Hunterdon Healthcare Infusion Center at 908-237-4240.
Join our readers whose generous donations are making it possible for you to read our news coverage. Help keep local journalism alive and our community strong. Donate today.
